Kevin DeLong

562 total citations
12 papers, 383 citations indexed

About

Kevin DeLong is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Kevin DeLong has authored 12 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Microbiology and 3 papers in Immunology. Recurrent topics in Kevin DeLong's work include Reproductive tract infections research (7 papers), Urinary Tract Infections Management (3 papers) and Reproductive System and Pregnancy (3 papers). Kevin DeLong is often cited by papers focused on Reproductive tract infections research (7 papers), Urinary Tract Infections Management (3 papers) and Reproductive System and Pregnancy (3 papers). Kevin DeLong collaborates with scholars based in United States, Australia and Denmark. Kevin DeLong's co-authors include Laura M. Ensign, Hannah C. Zierden, Fareeha Zulfiqar, Richard A. Cone, Rachel Shapiro, Thomas R. Moench, David Tyssen, Yingying Wang, Thuy Hoang and Joshua A. Hayward and has published in prestigious journals such as Advanced Drug Delivery Reviews, Science Translational Medicine and PLoS Pathogens.

In The Last Decade

Kevin DeLong

11 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin DeLong United States 9 181 147 108 102 53 12 383
Jai Marathe United States 7 95 0.5× 83 0.6× 58 0.5× 63 0.6× 33 0.6× 16 283
Yuanjun Liu China 11 316 1.7× 188 1.3× 83 0.8× 96 0.9× 26 0.5× 38 431
Philipp Grob Germany 12 256 1.4× 189 1.3× 162 1.5× 34 0.3× 51 1.0× 15 555
Maria Tollin Sweden 7 292 1.6× 97 0.7× 175 1.6× 197 1.9× 31 0.6× 7 642
S Kovachev Bulgaria 8 175 1.0× 159 1.1× 118 1.1× 30 0.3× 15 0.3× 38 323
Aiping Fan China 13 332 1.8× 327 2.2× 81 0.8× 106 1.0× 39 0.7× 23 513
Irene Y. Xie Canada 5 210 1.2× 139 0.9× 164 1.5× 99 1.0× 31 0.6× 6 483
Mariolina Bruno Netherlands 11 100 0.6× 174 1.2× 64 0.6× 174 1.7× 14 0.3× 23 442
Jean-Pierre Ménard France 7 293 1.6× 232 1.6× 95 0.9× 46 0.5× 59 1.1× 16 432
Mohak Mhatre United States 7 117 0.6× 96 0.7× 37 0.3× 46 0.5× 40 0.8× 14 239

Countries citing papers authored by Kevin DeLong

Since Specialization
Citations

This map shows the geographic impact of Kevin DeLong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin DeLong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin DeLong more than expected).

Fields of papers citing papers by Kevin DeLong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin DeLong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin DeLong. The network helps show where Kevin DeLong may publish in the future.

Co-authorship network of co-authors of Kevin DeLong

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin DeLong. A scholar is included among the top collaborators of Kevin DeLong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin DeLong. Kevin DeLong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shapiro, Rachel, et al.. (2024). Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice. Drug Delivery and Translational Research. 15(2). 609–620.
2.
Shapiro, Rachel, Arindom Pal, David Bartee, et al.. (2024). Investigating inhibitors of 1-deoxy- d -xylulose 5-phosphate synthase in a mouse model of UTI. Microbiology Spectrum. 12(4). e0389623–e0389623. 2 indexed citations
3.
Zierden, Hannah C., Kevin DeLong, Fareeha Zulfiqar, et al.. (2023). Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome. Frontiers in Cellular and Infection Microbiology. 13. 1015625–1015625. 9 indexed citations
4.
Vomstein, Kilian, Elleke F. Bosma, Brynjulf Mortensen, et al.. (2023). Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case study. EClinicalMedicine. 61. 102070–102070. 49 indexed citations
5.
Shapiro, Rachel, et al.. (2022). In vitro and ex vivo models for evaluating vaginal drug delivery systems. Advanced Drug Delivery Reviews. 191. 114543–114543. 31 indexed citations
6.
Zierden, Hannah C., Kevin DeLong, Peter Dimitrion, et al.. (2021). Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth. Science Translational Medicine. 13(576). 39 indexed citations
7.
Zierden, Hannah C., et al.. (2021). Next generation strategies for preventing preterm birth. Advanced Drug Delivery Reviews. 174. 190–209. 41 indexed citations
8.
Hoang, Thuy, Kevin DeLong, Seth M. Bloom, et al.. (2020). The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis. PLoS Pathogens. 16(1). e1008236–e1008236. 52 indexed citations
9.
DeLong, Kevin, Fareeha Zulfiqar, Diane E. Hoffmann, Anita J. Tarzian, & Laura M. Ensign. (2019). Vaginal Microbiota Transplantation: The Next Frontier. The Journal of Law Medicine & Ethics. 47(4). 555–567. 31 indexed citations
10.
DeLong, Kevin, Fareeha Zulfiqar, Hannah C. Zierden, et al.. (2019). Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant. Frontiers in Cellular and Infection Microbiology. 9. 306–306. 41 indexed citations
11.
Tyssen, David, Yingying Wang, Joshua A. Hayward, et al.. (2018). Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid. mSphere. 3(4). 84 indexed citations
12.
Becker, Christoph R., et al.. (2011). PRS18 Economic Burden of Cystic Fibrosis in the US: Costs of Care By Disease Severity and Age. Value in Health. 14(7). A490–A490. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026